This article is more than 5 years old. Information may no longer be current.

Aton releases generic glaucoma eye drop

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

LAWRENCEVILLE, N.J. — Aton Pharma has launched an authorized generic version of its non-selective beta-adrenergic receptor blocking agent Timoptic-XE, the company announced in a press release.

Timolol maleate ophthalmic gel forming solution is indicated for treating elevated IOP in ocular hypertension or open-angle glaucoma patients, the release said.

"We are extremely pleased with the successful launch of the authorized generic for Timoptic-XE, and we are now highly confident in our ability to execute this type of program for other Aton products when the opportunity arises," Michael G. Wells, CEO of Aton Pharma, said in the release.

Aton will continue to distribute branded Timoptic-XE in addition to the generic, the release said.

Follow OSNSuperSite.com on Twitter.